// App-Quantinova.ai

2362 : Optimizing prostate cancer immunotherapy by reducing vaccine induced PD-1 expression

Researchers

Presenter

  • Christopher D. Zahm

Principal Investigators

  • Douglas G. McNeel

Medical Centers

  • Univ. of Wisconsin-Madison, Madison, WI.

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Synovial sarcoma

  • Prostate cancer

  • Sarcoma

  • Solid malignancies

Biomarkers

  • Adenomatous Polyposis Coli

  • Programmed cell death protein 1

  • Cluster of differentiation 8A

  • Human leukocyte antigen A2

  • SSX Family Member 2

  • T-cell receptor

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved